Abstract
Correction to: Leukemia (2012) 26, 2300–2301; doi:10.1038/leu.2012.93 Since the publication of this article, it has been brought to the authors’ attention that there are two instances where the word ‘bivalirudin’ has been incorrectly spelt as ‘bivaluridin’ (once in the title, the other on page 2). The authors would like to apologize for any inconvenience this may have caused.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have